{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:54:42Z","timestamp":1768679682736,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"4-6","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":87,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1053\/j.seminoncol.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T21:16:17Z","timestamp":1635282977000},"page":"283-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature"],"prefix":"10.1053","volume":"48","author":[{"given":"Jihe","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seun Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Khil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9599-4970","authenticated-orcid":false,"given":"Sun-Ju","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Joon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2021.10.002_bib0001","unstructured":"Moderna COVID-19 vaccine. 2021. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/moderna-covid-19-vaccine (Accessed 8\/4\/2021)."},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0002","unstructured":"Pfizer-BioNTech COVID-19 vaccine. 2021. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/pfizer-biontech-covid-19-vaccine.)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0003","unstructured":"Janssen COVID-19 vaccine. 2021. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/janssen-covid-19-vaccine.)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0004","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0006","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0007","unstructured":"Local reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 vaccine. 2021. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html (Accessed August 4, 2021)."},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0008","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January-October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0009","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12149-011-0568-x","article-title":"Axillary lymph node accumulation on FDG-PET\/CT after influenza vaccination","volume":"26","author":"Shirone","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0010","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.28.9.1194","article-title":"Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination","volume":"28","author":"Studdiford","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0011","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s00259-011-1729-9","article-title":"Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination","volume":"38","author":"Thomassen","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0012","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/RLU.0b013e3182177322","article-title":"Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine","volume":"36","author":"Burger","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0013","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.1966.03110160148051","article-title":"Live, attenuated measles virus vaccine. Inguinal lymphadenopathy complicating administration","volume":"198","author":"Dorfman","year":"1966","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.inf.0000199259.04970.d1","article-title":"Tuberculous lymphadenitis as a cause of persistent cervical lymphadenopathy in children from a tuberculosis-endemic area","volume":"25","author":"Marais","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0015","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1148\/radiol.2021210236","article-title":"Adenopathy following COVID-19 vaccination","volume":"299","author":"Washington","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.1794","article-title":"Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity on imaging","author":"Adin","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2021210008","article-title":"Axillary lymphadenopathy after mRNA COVID-19 vaccination","volume":"3","author":"Ahn","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0018","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/RLU.0000000000003597","article-title":"COVID-19 mRNA vaccination-induced lymphadenopathy mimics lymphoma progression on FDG PET\/CT","volume":"46","author":"Xu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0019","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s00259-021-05274-7","article-title":"COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET\/CT","volume":"48","author":"Nawwar","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0020","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.21.25728","article-title":"COVID-19 vaccination-related uptake on FDG PET\/CT: an emerging dilemma and suggestions for management","author":"McIntosh","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0021","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00259-021-05278-3","article-title":"COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET\/CT in a patient affected by melanoma","volume":"48","author":"Avner","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0022","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1148\/radiol.2021210386","article-title":"Evolution of lymphadenopathy at PET\/MRI after COVID-19 vaccination","volume":"299","author":"Hanneman","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0023","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.121.262108","article-title":"FDG avid axillary lymph nodes after COVID-19 vaccination","author":"Johnson","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0024","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/RLU.0000000000003636","article-title":"FDG PET findings post-COVID vaccinations: signs of the times?","volume":"46","author":"Moghimi","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0025","first-page":"e13524","article-title":"Lymphadenopathy associated with the COVID-19 vaccine","volume":"13","author":"Hiller","year":"2021","journal-title":"Cureus"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0026","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.acra.2021.04.007","article-title":"Lymphadenopathy following COVID-19 vaccination: imaging findings review","volume":"28","author":"Keshavarz","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0027","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.1148\/radiol.2021210275","article-title":"Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients","volume":"300","author":"\u00d6z\u00fctemiz","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0028","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.21.25604","article-title":"Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination","author":"Edmonds","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0029","doi-asserted-by":"crossref","first-page":"E323","DOI":"10.1148\/radiol.2021210436","article-title":"Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: radiology scientific expert panel","volume":"300","author":"Becker","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bjoms.2021.02.002","article-title":"Supraclavicular lymphadenopathy following COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?","volume":"59","author":"Mitchell","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0031","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2021.01.016","article-title":"Unilateral axillary adenopathy in the setting of COVID-19 vaccine","volume":"75","author":"Mehta","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0032","doi-asserted-by":"crossref","first-page":"W27","DOI":"10.2214\/AJR.21.25683","article-title":"Unilateral axillary lymphadenopathy after coronavirus disease (COVID-19) vaccination","volume":"216","author":"Cellina","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0033","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.radcr.2021.04.015","article-title":"Unilateral axillary lymphadenopathy following COVID-19 vaccination: a case report and imaging findings","volume":"16","author":"Dominguez","year":"2021","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0034","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacr.2021.03.001","article-title":"Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists across specialties","volume":"18","author":"Lehman","year":"2021","journal-title":"J Am Coll Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13244-014-0367-8","article-title":"A practical approach to imaging the axilla","volume":"6","author":"Dialani","year":"2015","journal-title":"Insights Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0036","doi-asserted-by":"crossref","unstructured":"Peters G, Jones CM. Unilateral axillary adenopathy with unremarkable breast imaging\u2014differential diagnoses. 2012;16:3.","DOI":"10.7196\/sajr.702"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0037","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1445-2197.2008.04443.x","article-title":"Preoperative ultrasound of axillary lymph nodes in patients with breast cancer","volume":"78","author":"Clark","year":"2008","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0038","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/028418600750013014","article-title":"Imaging of axillary lymph nodes","volume":"39","author":"Lernevall","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0039","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.crad.2015.04.019","article-title":"Retrospective preoperative assessment of the axillary lymph nodes in patients with breast cancer and literature review","volume":"70","author":"Saffar","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0040","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.radcr.2021.05.031","article-title":"Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 vaccination","volume":"16","author":"Aalberg","year":"2021","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0041","first-page":"1","article-title":"Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services","author":"Abou-Foul","year":"2021","journal-title":"J Laryngol Otol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0042","article-title":"COVID-19 vaccination manifesting as unilateral lymphadenopathies detected by 18F-Choline PET\/CT","author":"Albano","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0043","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0044","article-title":"FDG-avid ipsilateral iliac and inguinal lymphadenopathy after COVID-19 vaccination with thigh injection","author":"Bass","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0045","article-title":"DOTATATE uptake in an axillary lymph node after COVID-19 vaccination","author":"Brophy","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0046","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.crad.2021.04.010","article-title":"Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines","volume":"76","author":"Brown","year":"2021","journal-title":"Clin Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0047","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/lungindia.lungindia_91_21","article-title":"Unilateral lymphadenopathy after COVID-19 vaccination","volume":"38","author":"Canan","year":"2021","journal-title":"Lung India"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0048","first-page":"e15050","article-title":"A case of cervical lymphadenopathy after vaccination against COVID-19","volume":"13","author":"Cardoso","year":"2021","journal-title":"Cureus"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0049","article-title":"Lymphadenopathy after the anti-COVID-19 Vaccine: multiparametric ultrasound findings","volume":"10","author":"Cocco","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0050","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s00259-021-05389-x","article-title":"Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy","volume":"48","author":"Cohen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.690443","article-title":"Interference of COVID-19 vaccination with PET\/CT leads to unnecessary additional imaging in a patient with metastatic cutaneous melanoma-case report","volume":"11","author":"Czepczy\u0144ski","year":"2021","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0052","first-page":"1","article-title":"Ultrasound and shear-wave elastography patterns of COVID-19 mRNA vaccine-related axillary, supra and subclavicular lymphadenopathy","author":"D'Auria","year":"2021","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0053","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1148\/radiol.2020210030","article-title":"Imaging of COVID-19 vaccination at FDG PET\/CT","volume":"299","author":"Eifer","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0054","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.acra.2021.06.003","article-title":"COVID-19 vaccination induced lymphadenopathy in a specialized breast imaging clinic in Israel: analysis of 163 cases","volume":"28","author":"Faermann","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0055","article-title":"Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine","author":"Felices-Farias","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0056","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.10.2100193","article-title":"Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021","volume":"26","author":"Fernandez-Prada","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174340","article-title":"The Day after Mass COVID-19 Vaccination: Higher Hypermetabolic Lymphadenopathy Detection on PET\/CT and Impact on Oncologic Patients Management","volume":"13","author":"Ferrari","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0058","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3399\/bjgp21X716117","article-title":"Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management","volume":"71","author":"Garreffa","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0059","article-title":"Lymphadenopathy after BNT162b2 Covid-19 vaccine: preliminary ultrasound findings","volume":"10","author":"Granata","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0060","doi-asserted-by":"crossref","first-page":"w20557","DOI":"10.4414\/smw.2021.20557","article-title":"Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy","volume":"151","author":"Hagen","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0061","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clinimag.2021.05.031","article-title":"Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography","volume":"79","author":"Kim","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0062","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000003697","article-title":"DOTATATE -avid bilateral axilla and subpectoral lymphadenopathy induced from COVID-19 mRNA vaccination visualized on PET\/CT","author":"Lu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0063","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bjoms.2021.04.008","article-title":"COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic\u2014a follow up audit","volume":"59","author":"Mitchell","year":"2021","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0064","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2214\/AJR.21.25651","article-title":"COVID-19 vaccination-associated axillary adenopathy: imaging findings and follow-up recommendations in 23 women","volume":"217","author":"Mortazavi","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0065","article-title":"Features of systemic immune response from COVID-19 vaccination on 18F-FDG PET\/CT","author":"Nawwar","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0066","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00259-021-05279-2","article-title":"Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F]Choline PET\/CT-not only an FDG finding","volume":"48","author":"Nawwar","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0067","article-title":"Axillary lymphadenopathy after coronavirus disease 2019 vaccinations in patients with thoracic malignancy: incidence, predisposing factors, and imaging characteristics","author":"Nishino","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0068","article-title":"Lessons learned from post-COVID-19 vaccination PET\/CT studies","author":"Orevi","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0069","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejca.2021.06.023","article-title":"Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: a monocentre study","volume":"154","author":"Placke","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0070","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/S1470-2045(21)00197-2","article-title":"COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma","volume":"22","author":"Prieto","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0071","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyab129","article-title":"68Ga-DOTATOC-avid lymphadenopathies induced from COVID-19 mRNA vaccination","author":"Pudis","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0072","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/jamaoncol.2021.3127","article-title":"Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination","volume":"7","author":"Robinson","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0073","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/jpgm.JPGM_254_21","article-title":"Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine","volume":"67","author":"Roca","year":"2021","journal-title":"J Postgrad Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0074","article-title":"Case report of lymph node activation mimicking cancer progression: a false positive F(18) FDG PET CT after COVID-19 vaccination","volume":"4","author":"Schapiro","year":"2021","journal-title":"Curr Probl Cancer Case Rep"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0075","first-page":"1","article-title":"Frequency and characteristics of nodal and deltoid FDG and (11)C-Choline uptake on PET performed after COVID-19 vaccination","author":"Schroeder","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0076","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.radcr.2021.04.053","article-title":"COVID-19 vaccine induced axillary and pectoral lymphadenopathy on PET scan","volume":"16","author":"Singh","year":"2021","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0077","first-page":"1","article-title":"[(18)F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET\/CT: frequency, intensity, and potential clinical impact","author":"Skawran","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0078","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2967\/jnmt.121.262008","article-title":"Reactive axillary lymphadenopathy to COVID-19 vaccination on (18)F-FDG PET\/CT","volume":"49","author":"Smith","year":"2021","journal-title":"J Nucl Med Technol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0079","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.268","article-title":"Hypermetabolic lymphadenopathy on positron emission tomography scan following COVID-19 vaccination: a mimicker of disease progression in Hodgkin lymphoma","author":"Suleman","year":"2021","journal-title":"EJHaem"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0080","article-title":"Supraclavicular and axillary lymphadenopathy induced by COVID-19 vaccination on 18F-fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET\/CT","author":"Surasi","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0081","doi-asserted-by":"crossref","DOI":"10.1002\/dc.24863","article-title":"COVID-19 post-vaccination lymphadenopathy: Report of cytological findings from fine needle aspiration biopsy","author":"Tan","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0082","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.265","article-title":"Lymphadenopathy with florid lymphoid and Langerhans cell hyperplasia and hemophagocytosis mimicking lymphoma after COVID-19 mRNA vaccination","author":"Tintle","year":"2021","journal-title":"EJHaem"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0083","article-title":"Post COVID-19 vaccine adenopathy: first Brazilian report","volume":"47","author":"Viana","year":"2021","journal-title":"J Bras Pneumol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0084","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000003683","article-title":"The challenge of staging breast cancer with PET\/CT in the era of COVID vaccination","author":"Brown","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0085","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s00259-021-05331-1","article-title":"Medical imaging in times of pandemic: focus on the cornerstones of successful imaging","volume":"48","author":"Delgado Bolton","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0086","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.acra.2021.07.022","article-title":"Managing the risk of delayed breast cancer screening versus COVID-19 vaccination associated axillary lymphadenopathy","volume":"28","author":"Garver","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0087","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10549-021-06293-6","article-title":"COVID-19 vaccination and breast cancer surgery timing","volume":"188","author":"Ko","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0088","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2214\/AJR.21.25688","article-title":"Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach","volume":"217","author":"Lehman","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0089","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13244-021-01062-x","article-title":"Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)","volume":"12","author":"Schiaffino","year":"2021","journal-title":"Insights Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2021210038","article-title":"COVID-19 vaccination-related lymphadenopathy: what to be aware of","volume":"3","author":"Tu","year":"2021","journal-title":"Radiol Imaging Cancer"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0091","unstructured":"Prevention Ca. The Moderna COVID-19 vaccine's local reactions, systemic reactions, adverse events, and serious adverse events. 2021: Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html."},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0092","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00259-021-05314-2","article-title":"Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation","volume":"48","author":"Cohen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0093","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clinimag.2021.07.011","article-title":"COVID-19 vaccine-related unilateral axillary lymphadenopathy: pattern on screening breast MRI allowing for a benign assessment","volume":"80","author":"Plaza","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102220","article-title":"Coordination and optimization of FDG PET\/CT and COVID-19 vaccination; lessons learned in the early stages of mass vaccination","volume":"98","author":"McIntosh","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0095","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1148\/radiol.2021210886","article-title":"Prevalence of increased FDG PET\/CT axillary lymph node uptake beyond 6 weeks after mRNA COVID-19 vaccination","volume":"300","author":"Eshet","year":"2021","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0096","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clinimag.2021.07.015","article-title":"Mammographic and sonographic findings in the breast and axillary tail following a COVID-19 vaccine","volume":"80","author":"Locklin","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0097","doi-asserted-by":"crossref","DOI":"10.1177\/0846537121998949","article-title":"The Canadian Society of Breast Imaging Recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination - update","author":"Seely","year":"2021","journal-title":"Can Assoc Radiol J"},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0098","unstructured":"Committee SoBIPCaD. SBI recommendations for the management of axillary adenopathy in patients with recent COVID-19 vaccination. 2021."},{"key":"10.1053\/j.seminoncol.2021.10.002_bib0099","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","article-title":"Estimation of the number of women living with metastatic breast cancer in the United States","volume":"26","author":"Mariotto","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775421000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775421000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:57:01Z","timestamp":1758805021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775421000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":99,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0093775421000695"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2021.10.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}